Bending Adolescent Depression Trajectories Through Personalized Prevention
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80208
- University of Denver
-
-
Illinois
-
Champaign, Illinois, United States, 61820
- University of Illinois Urbana Champaign
-
-
New Jersey
-
Piscataway, New Jersey, United States, 08854
- Rutgers University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19146
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Currently in the 6th to 11th grades
- Adolescent and parent must be English-speaking
- Parental consent and adolescent consent
Exclusion Criteria:
- Presence of current Major Depressive Disorder, dysthymia, bipolar disorder, or significant psychosis
- Suicide attempt in the past week or significant suicidal ideation in the past week
- Presence of significant psychopathology or significant pervasive developmental delays that would make the group inappropriate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Interpersonal Psychotherapy- Adolescent Skills Training
|
A group prevention program that includes a 60-minute pre-group session, 8 weekly 90-minute group sessions, a 60-minute mid-group session, and 3 60-minute booster sessions.
IPT-AST focuses on psychoeducation and interpersonal skill-building to decrease interpersonal conflict and increase interpersonal support and competence.
Other Names:
|
|
Experimental: Coping with Stress
|
A group prevention program that consists of 8 acute 90-minute group sessions, 2 parent group sessions, and 3 continuation sessions lasting 60 minutes each.
Participants are taught to apply cognitive techniques to their personal thoughts, with the goal of generating effective counterarguments to unrealistic negative beliefs.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of a Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: Post intervention (approximately 3 months post baseline)
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
Post intervention (approximately 3 months post baseline)
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: 6-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
6-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: 12-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
12-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: 18-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
18-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: 24-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
24-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: 30-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
30-months post-intervention
|
|
Presence of A Major Depressive Episode or Dysthymia on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: 36-months post-intervention
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation.
|
36-months post-intervention
|
|
Children's Depression Inventory (CDI)
Time Frame: Post intervention (approximately 3 months after baseline)
|
Self-reported depression scores
|
Post intervention (approximately 3 months after baseline)
|
|
Children's Depression Inventory (CDI)
Time Frame: 6-months post-intervention
|
Self-reported depression scores
|
6-months post-intervention
|
|
Children's Depression Inventory (CDI)
Time Frame: 12-months post-intervention
|
Self-reported depression scores
|
12-months post-intervention
|
|
Children's Depression Inventory (CDI)
Time Frame: 18-months post-intervention
|
Self-reported depression scores
|
18-months post-intervention
|
|
Children's Depression Inventory (CDI)
Time Frame: 24-months post-intervention
|
Self-reported depression scores
|
24-months post-intervention
|
|
Children's Depression Inventory (CDI)
Time Frame: 30-months post-intervention
|
Self-reported depression scores
|
30-months post-intervention
|
|
Children's Depression Inventory (CDI)
Time Frame: 36-months post-intervention
|
Self-reported depression scores
|
36-months post-intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Children's Global Assessment Scale (CGAS)
Time Frame: Post Intervention (approximately 3 months following baseline)
|
Assesses global functioning
|
Post Intervention (approximately 3 months following baseline)
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: 6-months followup
|
Assesses global functioning
|
6-months followup
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: 12-months followup
|
Assesses global functioning
|
12-months followup
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: 18-months followup
|
Assesses global functioning
|
18-months followup
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: 24-months followup
|
Assesses global functioning
|
24-months followup
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: 30-months followup
|
Assesses global functioning
|
30-months followup
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: 36-months followup
|
Assesses global functioning
|
36-months followup
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jami F Young, Ph.D., Children's Hospital of Philadelphia
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 17-013831
- R01MH077178 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.